Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(TSV:
LOVE
)
1.240
-0.020 (-1.59%)
Streaming Delayed Price
Updated: 3:40 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about LOVE
Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025
January 27, 2025
From
Cannara Biotech (Québec) Inc.
Via
GlobeNewswire
Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike
December 16, 2024
From
Cannara Biotech (Québec) Inc.
Via
GlobeNewswire
Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024
December 12, 2024
From
Cannara Biotech (Québec) Inc.
Via
GlobeNewswire
Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability
November 25, 2024
Vertically integrated cannabis producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Monday its fourth quarter and full fiscal 2024 financial and operating results ended...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
November 25, 2024
From
Cannara Biotech (Québec) Inc.
Via
GlobeNewswire
Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
July 23, 2024
Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Reports Q3 2024 Financial Results
July 23, 2024
From
Cannara Biotech (Québec) Inc.
Via
GlobeNewswire
Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
May 01, 2024
Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68%...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.